Market

Income Statement

You can view the Income Statement for the last 5 years.

INCOME STATEMENT

Akums Drugs & Pharmaceuticals Ltd.

GO
Market Cap. ( ₹ in Cr. ) 8136.48 P/BV 2.53 Book Value ( ₹ ) 204.41
52 Week High/Low ( ₹ ) 623/409 FV/ML 2/1 P/E(X) 31.88
Book Closure 03/07/2026 EPS ( ₹ ) 16.21 Div Yield (%) 0.00
(₹ in Crs.)

ParticularsMar 26Mar 25Mar 24Mar 23Mar 22
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue2.002.002.002.002.00
      
      
INCOME     
Revenue From Operations [Net]4359.024013.883971.213442.213581.60
Other Operating Revenues0.00104.28206.98212.6190.30
Total Operating Revenues4359.024118.164178.183654.823671.89
      
Other Income128.7352.1234.0346.1122.63
Total Revenue4487.744170.284212.213700.933694.52
      
EXPENSES     
Cost Of Materials Consumed2298.682253.612278.372028.092038.59
Purchase Of Stock-In Trade201.00181.47259.53221.79394.21
Changes In Inventories Of FG,WIP And Stock-In Trade13.84-1.6512.3424.04-87.74
Employee Benefit Expenses753.82715.82646.86590.13507.76
Finance Costs94.0734.6050.6146.2516.66
Depreciation And Amortisation Expenses154.55153.45125.64112.8194.68
Other Expenses569.65504.42858.10452.83910.80
Total Expenses4085.623841.724231.453475.933874.95
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax402.13328.56-19.24225.00-180.42
      
Exceptional Items-20.0216.70-26.03-74.50-12.98
Profit/Loss Before Tax382.10345.25-45.28150.50-193.40
      
Tax Expenses-Continued Operations     
Current Tax125.7081.3774.0378.1369.05
Deferred Tax0.00-79.43-103.32-27.26-6.04
Tax For Earlier Years0.00-0.46-16.771.61-5.33
Total Tax Expenses125.701.48-46.0752.4857.68
Profit/Loss After Tax And Before ExtraOrdinary Items256.40343.780.7998.02-251.08
      
Profit/Loss From Continuing Operations256.40343.780.7998.02-251.08
      
Profit/Loss For The Period256.40343.780.7998.02-251.08
      
Minority Interest-1.21-5.60-4.83-2.96-1.66
Share Of Profit/Loss Of Associates0.000.000.00-0.200.20
Consolidated Profit/Loss After MI And Associates255.19338.18-4.0494.86-252.54
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)16.6722.60-0.286.63-17.65
Diluted EPS (Rs.)16.6722.60-0.286.63-17.65
ParticularsMar 26
Months12
Source Of Info (AR = Annual Report, PR = Press Release)PR
FaceValue2.00
  
INCOME 
Revenue From Operations [Net]4359.02
Other Operating Revenues0.00
Total Operating Revenues4359.02
Other Income128.73
Total Revenue4487.74
EXPENSES 
Cost Of Materials Consumed2298.68
Purchase Of Stock-In Trade201.00
Changes In Inventories Of FG,WIP And Stock-In Trade13.84
Employee Benefit Expenses753.82
Finance Costs94.07
Depreciation And Amortisation Expenses154.55
Other Expenses569.65
Total Expenses4085.62
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax402.13
Exceptional Items-20.02
Profit/Loss Before Tax382.10
Tax Expenses-Continued Operations 
Current Tax125.70
Deferred Tax0.00
Tax For Earlier Years0.00
Total Tax Expenses125.70
Profit/Loss After Tax And Before ExtraOrdinary Items256.40
Profit/Loss From Continuing Operations256.40
Profit/Loss For The Period256.40
Minority Interest-1.21
Share Of Profit/Loss Of Associates0.00
Consolidated Profit/Loss After MI And Associates255.19
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)16.67
Diluted EPS (Rs.)16.67
Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.